ERIS Lifesciences Ltd is engaged in the business of manufacture and marketing of pharmaceutical products.
Financial Results:
ERIS Lifesciences Ltd reported Revenues for Q4FY24 of ₹551.00 Crores up from ₹403.00 Crore year on year, a rise of 36.72%.
Total Expenses for Q4FY24 of ₹489.00 Crores up from ₹328.00 Crores year on year, a rise of 49.09%.
Consolidated Net Profit of ₹80.00 Crores up 31.15% from ₹61.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹5.22, up 8.52% from ₹4.81 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.